CFTR and viral infectious disease: These results underscore the significance of spike-dependent CFTR reduction following authentic virus infection, and highlight the potential of cardiac glycosides as possible treatments to prevent SARS-CoV-2 infection, CFTR loss and the subsequent inflammatory response.